| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/08/2005 | US20050197284 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 09/08/2005 | US20050196861 Physiologically active peptides |
| 09/08/2005 | US20050196810 Providing a library of peptides comprising a trpzip scaffold, contacting the library with the bioactive target molecule; selecting at least one peptide capable of forming a noncovalent complex with the bioactive target molecule from the library; isolating peptide |
| 09/07/2005 | EP1571450A2 Cartilage Resorption assays |
| 09/07/2005 | EP1571160A1 Kit for assaying human low-molecular weight cd14 and antibody |
| 09/07/2005 | EP1571156A1 Physiologically active peptides |
| 09/07/2005 | EP1570272A2 Identification of agonistic autoantibodies |
| 09/07/2005 | EP1569956A2 Glycogen synthase kinase-3 inhibitors |
| 09/07/2005 | EP1569678A2 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 09/07/2005 | CN1666106A Method for enriching and tracking pathologic modified prions-proteins (PrP) |
| 09/07/2005 | CN1217697C Peptide antagonists of zonulin and methods for use of same |
| 09/06/2005 | US6939947 administering glycoproteins as antibiotics for prophylaxis of bacterial infections; vancomycin derivatives; peptide antibiotics |
| 09/06/2005 | US6939946 Ring modified cyclic peptide analogs |
| 09/06/2005 | US6939945 Synthetic peptide for use as tool in human therapeutics and diagnostics |
| 09/06/2005 | US6939880 Compounds with growth hormone releasing properties |
| 09/06/2005 | US6939854 enzyme inhibitors comprising peptide fragments, conjugated to boronic acids ,forming esters such as 1-amino-3-phenylpropylboronic acid (+)-pinanediol ester, used for prophylaxis of viral diseases |
| 09/06/2005 | US6939693 Enantioselective oligomerization of α-hydroxy carboxylic acids and α-amino acids |
| 09/06/2005 | US6939543 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/06/2005 | US6939532 Versatile hydrophilic dyes |
| 09/06/2005 | CA2250693C Compositions and methods for taxol biosynthesis |
| 09/02/2005 | CA2499160A1 Releasable polymer arrays |
| 09/01/2005 | WO2005080414A1 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| 09/01/2005 | WO2005079747A1 Pharmaceutical preparation for the oral cavity |
| 09/01/2005 | WO2005079300A2 Protein kinase inhibitors and methods for identifying same |
| 09/01/2005 | WO2005004792A3 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 09/01/2005 | WO2004087742A3 Peptides for reducing symptoms of toxic shock syndrome and septic shck |
| 09/01/2005 | WO2004062475A3 Fluorescent assays for protein kinases |
| 09/01/2005 | WO2004042019A3 Systems for capture and analysis of biological particles and methods using the systems |
| 09/01/2005 | WO2004020405A3 Modified transferrin fusion proteins |
| 09/01/2005 | WO2004009540A8 Methods and kits for transferases |
| 09/01/2005 | WO2003013426A3 Multivalent synthetic vaccine for cancer |
| 09/01/2005 | US20050192228 A cinnamoyl-glycyl-L-phenylalanyl-L-prolinamide, cinnamoyl-isoleucyl-phenylalanyl-L-proline ethylamide and cinnamoyl-isoleucyl-isoleucyl-prolineamide; apoptosis resistance; reversing of nerve degeneration, particularly of hippocampal cells Alzheimer's and Parkinson's disease; congnition activators |
| 09/01/2005 | US20050192214 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 09/01/2005 | US20050191718 Methods for measuring phosphatase activity |
| 09/01/2005 | US20050191240 Peptide analogs of neurotensin resistant to enzymatic degradation and retain high binding affinity for neurotensin receptors; metal chelating group on one end; replacing Arg8 with Gly(PipAm) ((N-amidinopiperidinyl)glycine) for example; useful for diagnostic and therapeutic purposes |
| 08/31/2005 | EP1568707A1 Antihypertensive peptides from casein hydrolysates |
| 08/31/2005 | EP1568373A2 Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions |
| 08/31/2005 | EP1567857A2 Method for screening modulators of mitochondrial functioning |
| 08/31/2005 | EP1567641A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 08/31/2005 | EP1567554A1 Icam-4 binding sites |
| 08/31/2005 | EP1567546A2 Aza-peptides |
| 08/31/2005 | EP1567545A2 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 08/31/2005 | EP1567199A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 08/31/2005 | CN1662552A Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 08/31/2005 | CN1662551A Antagonistic peptides of prostaglandin e2 receptor subtype ep4 |
| 08/31/2005 | CN1660893A Section of synthesized peptide S28-42 of troponin I of human cardiac muscle and application |
| 08/31/2005 | CN1660892A Oxidation resistant bioactive peptide of halobios and preparation method |
| 08/31/2005 | CN1660891A Small peptide sequence of combined site between envelope protein E2 of close hepatitis C virus and human CD81 |
| 08/31/2005 | CN1660889A Low hemolytic antibacterial peptide and its application |
| 08/31/2005 | CN1660888A Peptide of decreasing blood pressure of protein of acetes chinensis, preparing method and application |
| 08/31/2005 | CN1216992C Immunomodulators |
| 08/31/2005 | CN1216900C Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 08/31/2005 | CN1216637C Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 08/30/2005 | US6936689 Peptide antagonists of zonulin and methods for use of the same |
| 08/30/2005 | US6936687 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 08/30/2005 | US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET) |
| 08/30/2005 | US6936431 Anticancer, antitumor agents; measuring farnesylation of cellular protein |
| 08/30/2005 | US6936423 Anti-LTNF for in vitro assay of biological toxins |
| 08/25/2005 | WO2005077971A1 Novel heparin-binding peptide designed from heparin-binding site of snake poison-origin vascular endothelial growth factor (vegf)-like protein and use tehreof |
| 08/25/2005 | WO2005077970A1 Novel heparin-binding peptide designed from heparin-binding site of snake venom-origin vascular endothelial growth factor (vegf)-like protein and use thereof |
| 08/25/2005 | WO2005077969A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 08/25/2005 | WO2005077071A2 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | WO2005076886A2 Prostasin substrates and inhibitors |
| 08/25/2005 | WO2005059124A3 Isozyme-specific antagonists of protein kinase c |
| 08/25/2005 | WO2005021584A3 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus |
| 08/25/2005 | US20050187164 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 08/25/2005 | US20050187163 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences |
| 08/25/2005 | US20050187162 Novel peptide with osteogenic activity |
| 08/25/2005 | US20050187161 peptide sequences that selectively bind to fungal surface molecules; Biopanning and Rapid Analysis of Selective Interactive Ligands (BRASIL) provides for rapid and efficient separation of phage that bind to fungal surface molecules |
| 08/25/2005 | US20050187156 Isozyme-specific antagonists of protein kinase C |
| 08/25/2005 | US20050187152 Prevention and treatment of hypergastrinemia |
| 08/25/2005 | US20050187147 Compositions and methods for increasing drug efficiency |
| 08/25/2005 | US20050187145 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin |
| 08/25/2005 | US20050186634 Peptides for use in culture media |
| 08/25/2005 | US20050186201 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 08/25/2005 | US20050186197 Peptide inhibitors of beta lactamases |
| 08/25/2005 | CA2819492A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2555666A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2554999A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 08/24/2005 | EP1566442A2 Preparation and use of a human antibody gene bank (human antibody libraries) |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565185A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 08/24/2005 | EP1565160A2 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 08/24/2005 | EP1451207A4 Labeling reagent and methods of use |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | CN1659436A Method for isolating ligands |
| 08/24/2005 | CN1659432A Method for detecting ligands and targets in a mixture |
| 08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 08/24/2005 | CN1659183A Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 08/24/2005 | CN1658905A Modified byrodin 1 with reduced immunogenicity |
| 08/24/2005 | CN1658896A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1216073C Bioactive peptide of sepuence No.4 |
| 08/24/2005 | CN1216072C Bioactive peptide of sequence No.5 |
| 08/24/2005 | CN1216071C Bioactive peptide of sequcene No.27 |
| 08/24/2005 | CN1216070C Bioactive peptide sequence No.20 |
| 08/24/2005 | CN1216069C Bioctive peptide of sequence No.25 |
| 08/24/2005 | CN1216068C Bioactive peptide of sequence No.14 |
| 08/24/2005 | CN1216067C Bioactive peptide of sequence No.15 |
| 08/24/2005 | CN1215774C Albumen oligo peptide and preparing method thereof |